A detailed history of Glen Eagle Advisors, LLC transactions in Enovis Corp stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 12 shares of ENOV stock, worth $576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$576
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$44.56 - $62.43 $534 - $749
12 New
12 $542,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.6B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.